Identification of a potent agonist of the orphan nuclear receptor Nurr1.
Dubois
Celine
C
Novartis Institutes for Biomedical Research, Novartis Pharma AG, WKL-122.243, 4002 Basel, Switzerland.
Hengerer
Bastian
B
Mattes
Henri
H
D000818:Animals; D001562:Benzimidazoles / Q000138:chemical synthesis / Q000494:pharmacology; D002493:Central Nervous System Diseases / Q000188:drug therapy; D002851:Chromatography, High Pressure Liquid; D004268:DNA-Binding Proteins / Q000819:agonists* / Q000235:genetics / Q000502:physiology; D004298:Dopamine / Q000378:metabolism / Q000502:physiology; D006801:Humans; D008024:Ligands; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D014157:Transcription Factors / Q000819:agonists* / Q000235:genetics / Q000502:physiology
D001562:Benzimidazoles; D004268:DNA-Binding Proteins; D008024:Ligands; C539882:NR4A2 protein, human; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D014157:Transcription Factors; D004298:Dopamine